Category: <span>Mesothelioma News</span>

Idiopathic pulmonary fibrosis cases linked with asbestos exposure

A proportion of idiopathic pulmonary fibrosis (IPF) cases may be linked with asbestos exposure, according to the results of a new study. If confirmed, the findings would mean that current treatment strategies need to be altered as people with a history…

Idiopathic pulmonary fibrosis cases linked with asbestos exposure

A proportion of idiopathic pulmonary fibrosis (IPF) cases may be linked with asbestos exposure, according to the results of a new study. If confirmed, the findings would mean that current treatment strategies need to be altered as people with a history…

Idiopathic pulmonary fibrosis cases linked with asbestos exposure

Munich, Germany: A proportion of idiopathic pulmonary fibrosis cases may be linked with asbestos exposure, according to the results of a new study. If confirmed, the findings would mean that current treatment strategies need to be altered as people wit…

The silent killer: The asbestos threat from East Moors steelworks – 36 years after it closed

In association with law firm Hugh James, we look at the ongoing risk of asbestos exposure – years after the closure of one of Wales’ biggest steelworks East Moors steelworks in Splott, Cardiff , was in operation throughout the 1960s and early 70s befor…

Previously Dismissed Fraud Case Restored By U.S. Third Circuit Court of Appeals

Third Circuit Court of Appeals Restores Dismissed Fraud Suit Against Law Firm and Client

SELLAS Life Sciences Group Signs Exclusive License Agreement For…

4, 2014 /PRNewswire/ — SELLAS Life Sciences Group , a Swiss-based development-stage biopharmaceutical company today announced that it has signed an exclusive global collaboration and license agreement with Memorial Sloan Kettering Cancer Center for th…

Rosetta Genomics Initiates Post-Marketing Registry Study of Its Cancer Origin Test

Global Study to Evaluate the Test’s Impact on Treatment Decisions and Outcomes When Therapy Is Directed at a Cancer’s Origin Rosetta Genomics Ltd. , a leading developer and provider of microRNA-based molecular diagnostics and therapeutics, announces th…